BIOMAT Database Logo BIOMAT Database Logo

"Thio-tepa" eye drops. 1970

J Foster

UI MeSH Term Description Entries
D009883 Ophthalmic Solutions Sterile solutions that are intended for instillation into the eye. It does not include solutions for cleaning eyeglasses or CONTACT LENS SOLUTIONS. Eye Drop,Eyedrop,Eyedrops,Ophthalmic Solution,Eye Drops,Drop, Eye,Drops, Eye,Solution, Ophthalmic,Solutions, Ophthalmic
D004355 Drug Stability The chemical and physical integrity of a pharmaceutical product. Drug Shelf Life,Drugs Shelf Lives,Shelf Life, Drugs,Drug Stabilities,Drugs Shelf Life,Drugs Shelf Live,Life, Drugs Shelf,Shelf Life, Drug,Shelf Live, Drugs,Shelf Lives, Drugs
D013852 Thiotepa A very toxic alkylating antineoplastic agent also used as an insect sterilant. It causes skin, gastrointestinal, CNS, and bone marrow damage. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), thiotepa may reasonably be anticipated to be a carcinogen (Merck Index, 11th ed). Thio-Tepa,Thiophosphamide,Triethylenethiophosphoramide,AI3-24916,Girostan,NSC-6396,Tespa,Tespamin,Tris(1-aziridinyl)phosphine Sulfide,AI3 24916,AI324916,NSC 6396,NSC6396,Thio Tepa

Related Publications

J Foster
[Synoviorthesis by thio-tepa].
January 1968, Revue du rhumatisme et des maladies osteo-articulaires,
J Foster
[Prolongatoon of homotransplant viability under the influence of thio-TEPA and thio-TEPA combined with hydrocortisone].
August 1969, Biulleten' eksperimental'noi biologii i meditsiny,
J Foster
Thermal enhancement of thio-TEPA cytotoxicity.
April 1973, Journal of the National Cancer Institute,
J Foster
Side-effect of topical Thio-tepa.
September 1969, American journal of ophthalmology,
J Foster
Intracavitary thio-TEPA for malignant effusions.
February 1962, The American surgeon,
J Foster
Triethylene thiophosphoramide (thio-tepa) and pterygium.
May 1966, American journal of ophthalmology,
J Foster
Long-term pharmacokinetics of thio-TEPA, TEPA and total alkylating activity following i.v. bolus administration of thio-TEPA in ovarian cancer patients.
January 1990, Cancer chemotherapy and pharmacology,
J Foster
[Effect of thio-TEPA on mice ovaries].
January 1968, Zhurnal obshchei biologii,
J Foster
[Agranulocytic reaction associated with thio-tepa therapy].
May 1971, Klinicheskaia meditsina,
J Foster
Bioassay of thio-TEPA for possible carcinogenicity.
January 1978, National Cancer Institute carcinogenesis technical report series,
Copied contents to your clipboard!